|Articles|November 1, 2004

Risk awareness more important than ever for isotretinoin

New York - Discussing "What's Up with Isotretinoin" at the recent American Academy of Dermatology Academy '04 here, John S. Strauss, M.D., reported that much of the recent attention on oral retinoids continues to focus on the pregnancy risk management aspects of its use for the treatment of acne.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME